α-Synuclein impairs macroautophagy: implications for Parkinson's disease

AR Winslow, CW Chen, S Corrochano… - Journal of Cell …, 2010 - rupress.org
Journal of Cell Biology, 2010rupress.org
Parkinson's disease (PD) is characterized pathologically by intraneuronal inclusions called
Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus
increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-
synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs
macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein
compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the …
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
rupress.org